Although the underlying mechanisms are still undetermined, irAEs caused by the activation of autoantigen-specific T cells upon PD-(L)1 inhibitors might indirectly reflect the killing ability of tumor-specific T cells [13]. This evidence concerns the gene CD274 and neoplasm.